Search

Displaying results 961 - 970 of 4860 in total
  1. Drug

    Cyproterone acetate

    go.drugbank.com/drugs/DB04839
    ApprovedInvestigational

    It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females.

    Mixtures: Diane mite - Dragees
  2. Drug

    Avatrombopag

    go.drugbank.com/drugs/DB11995
    ApprovedInvestigational

    [L2931] It is administered orally as the salt form avatrombopag maleate.

  3. Drug

    Ceftobiprole

    go.drugbank.com/drugs/DB04918
    ApprovedWithdrawn

    [L50467] It received its first approval in Canada in October 2017 for use in certain patients with bacterial pneumonia,[L50472] and was subsequently approved in the United States with additional indications

  4. Drug

    Dimethicone 410

    go.drugbank.com/drugs/DB14005
    Approved

    [A32462] It is formed by repeated polymeric units of -(CH3)2SiO- with a terminal trimethyl siloxy unit. … [L1769] It is currently recognized by the FDA as a skin protectant OTC ingredient for human use in a concentration of 1-30%.

  5. Drug

    Ulmus crassifolia pollen

    go.drugbank.com/drugs/DB10469
    Approved

    Ulmus crassifolia pollen is the pollen of the Ulmus crassifolia plant. Ulmus crassifolia pollen is mainly used in allergenic testing.

    Mixtures: 9 Tree Mix, 9 Tree Mix
  6. Drug

    Juniperus monosperma pollen

    go.drugbank.com/drugs/DB10727
    Approved

    Juniperus monosperma pollen is the pollen of the Juniperus monosperma plant. Juniperus monosperma pollen is mainly used in allergenic testing.

    Mixtures: Juniper Pollen Mix, Juniper Pollen Mix
  7. Drug

    Ocrelizumab

    go.drugbank.com/drugs/DB11988
    ApprovedInvestigational

    [L42895] It is a second-generation recombinant humanized monoclonal IgG1 antibody that selectively targets B-cells that express the CD20 antigen. … It was later approved by Health Canada in August 2017, making the drug the first available treatment for PPMS in both the US and Canada.

  8. Drug

    Rhodotorula mucilaginosa

    go.drugbank.com/drugs/DB10701
    Approved

    Rhodotorula mucilaginosa is a fungus which can provoke allergic reactions. Rhodotorula mucilaginosa is used in allergenic testing.

    Mixtures: Mold Mix C, Mold Mix C
  9. Drug

    Penicillium glaucum

    go.drugbank.com/drugs/DB14171
    Approved

    Penicillium glaucum allergenic extract is used in allergenic testing.

    Mixtures: Molds - Mold Mix 10, Molds - Mold Mix 4
  10. Drug

    Brimonidine

    go.drugbank.com/drugs/DB00484
    ApprovedInvestigational

    [A178951] It is considered to be a third generation alpha-2 aadrenergic receptor agonist, since it displays preferential binding at alpha-2 adrenoceptors over alpha-1 receptors. … It is marketed under the brand name Mirvaso.[L6535] Brimonidine is the first topical treatment approved for facial erythema of rosacea.[A178978]